Friday, September 30, 2016

Krystexxa


Generic Name: pegloticase (Intravenous route)

peg-LOE-ti-kase

Intravenous route(Solution)

Anaphylaxis and infusion reactions have been reported to occur during and after administration of pegloticase. Pegloticase should be administered in healthcare settings and by healthcare providers prepared to manage anaphylaxis and infusion reactions. Patients should be premedicated with antihistamines and corticosteroids and be closely monitored for an appropriate period of time for anaphylaxis after administration of pegloticase. Monitor serum uric acid levels prior to infusions and consider discontinuing treatment if levels increase to above 6 mg/dL, particularly when 2 consecutive levels above 6 mg/dL are observed .



Commonly used brand name(s)

In the U.S.


  • Krystexxa

Available Dosage Forms:


  • Solution

Pharmacologic Class: Enzyme


Uses For Krystexxa


Pegloticase injection is used to treat chronic gout in adult patients who have already been treated with other medicines that did not work well. Gout is a condition that is caused by too much uric acid in the blood (hyperuricemia).


Pegloticase injection works by causing less uric acid to be produced by the body. This medicine will not relieve a gout attack that has already started.


This medicine is to be administered only by or under the immediate supervision of your doctor.


Before Using Krystexxa


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of pegloticase injection in children. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of pegloticase injection in the elderly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency (a hereditary metabolic disorder affecting red blood cells) or

  • Hyperuricemia, asymptomatic (without noticeable symptoms)—Should not be used in patients with these conditions.

  • Congestive heart failure—Use with caution. May make this condition worse.

Proper Use of Krystexxa


A nurse or other trained health professional will give you this medicine in a hospital or clinic. This medicine is given through a needle placed in one of your veins.


This medicine must be given slowly, so the needle will remain in place for a few hours (up to 2 hours or longer). You may also receive medicines (e.g., antihistamines, corticosteroids) to help prevent possible allergic reactions to the injection.


This medicine is usually given every two weeks. If you miss a dose or forget to receive your medicine, call your doctor for instructions.


This medicine should come with a Medication Guide. Read and follow the instructions carefully. Ask your doctor if you have any questions.


Precautions While Using Krystexxa


Your doctor will check your progress closely while you are receiving this medicine. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to receive it. Blood tests may be needed to check for unwanted effects.


This medicine may cause a serious type of allergic reaction called anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor right away if you have a rash; hives; itching; dizziness; shortness of breath; swelling of your hands, face, mouth, or tongue; trouble with breathing or swallowing; or chest pain after you receive the medicine.


This medicine may cause infusion reactions, such as a rash, itching, or redness of the skin; difficulty with breathing; feeling of warmth or redness of the face, neck, arms and occasionally, upper chest; or chest discomfort or pain, while you are receiving the injection or within 2 hours after you receive it. Stop using this medicine and check with your doctor or nurse right away if you have any of these symptoms.


Patients of African or Mediterranean ancestry are at higher risk of serious side effects and should be carefully evaluated by their doctor before starting this medicine.


Gout flares may occur in the first three months when you start receiving this medicine. Do not stop receiving this medicine even if you have a gout flare. Your doctor may give you medicines (e.g., colchicine, non-steroidal antiinflammatory drug or NSAID) to reduce and prevent worsening of the gout.


Krystexxa Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor or nurse immediately if any of the following side effects occur:


More common
  • Chest pain or discomfort

  • cough

  • difficult or labored breathing

  • difficulty with swallowing

  • dizziness

  • facial swelling

  • fast heartbeat

  • fever or chills

  • flushing or redness of the skin

  • gout flare

  • headache

  • hives or welts

  • itching

  • nausea or vomiting

  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue

  • redness of the skin

  • shortness of breath

  • skin rash

  • tightness in the chest

  • unusual tiredness or weakness

  • unusually warm skin

  • wheezing

Rare
  • Decreased urine output

  • dilated neck veins

  • extreme fatigue

  • irregular breathing

  • irregular heartbeat

  • swelling of the face, fingers, feet, or lower legs

  • troubled breathing

  • weight gain

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Bruise

  • contusion

  • difficulty having a bowel movement (stool)

  • large, flat, blue, or purplish patches in the skin

  • muscle aches

  • sore throat

  • stuffy or runny nose

Less common
  • Vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Krystexxa side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Krystexxa resources


  • Krystexxa Side Effects (in more detail)
  • Krystexxa Use in Pregnancy & Breastfeeding
  • Krystexxa Drug Interactions
  • Krystexxa Support Group
  • 2 Reviews for Krystexxa - Add your own review/rating


  • Krystexxa Prescribing Information (FDA)

  • Krystexxa Consumer Overview

  • Krystexxa Monograph (AHFS DI)

  • Krystexxa MedFacts Consumer Leaflet (Wolters Kluwer)

  • Pegloticase Professional Patient Advice (Wolters Kluwer)



Compare Krystexxa with other medications


  • Gout

No comments:

Post a Comment